Iodide

Iodide

SCHEMBL2865870

COc1ccc(-c2ccccc2OS(=O)(=O)C(F)(F)F)cc1.I

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.46
BACE1 P56817 3/20 0.44
ABL1 P00519 1/20 0.44
ABCB1 P08183 1/20 0.44
BCR P11274 1/20 0.44
PTGS2 P35354 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
SYK P43405 1/20 0.43
AURKB Q96GD4 1/20 0.43
INCENP Q9NQS7 1/20 0.43
SLC22A12 Q96S37 1/20 0.42
PTPN1 P18031 1/20 0.42
MAPT P10636 3/20 0.41
TP53 P04637 2/20 0.41
NPC1 O15118 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL19066712 0.97 STAT3 (0.46) STAT3BACE1ABL1ABCB1BCR
Iodide SCHEMBL8737221 0.85 LMNA (0.43) PTGS2SYKALDH1A1LMNAHTT
Iodide SCHEMBL8733602 0.85 PTGS2 (0.46) STAT3PTGS2FFAR4
SCHEMBL367003 0.85 DRD2 (0.42) PTGS2TP53RAB9A
Iodide SCHEMBL8735171 0.83 SLC22A12 (0.49) STAT3PTGS2SLC22A12PTPN1MAPT
Iodide SCHEMBL8735177 0.82 PTGS2 (0.44) PTGS2MAPTTP53
Iodide SCHEMBL8735153 0.82 PTGS2 (0.39) PTGS2ALDH1A1HPGDFFAR4
Iodide SCHEMBL21220125 0.82 PTGS2 (0.39) PTGS2ALDH1A1FFAR4
Iodide SCHEMBL8005565 0.82 ABL1 (0.49) STAT3BACE1ABL1ABCB1BCR
Hydrogen Sulfide SCHEMBL27520693 0.82 PTGS2 (0.46) STAT3PTGS2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4968581-A High resolution photoresist of imide containing polymers HOECHST CELANESE CORPORATION (US) 1990-11-06 US claimed
US-4912018-A High resolution photoresist based on imide containing polymers HOECHST CELANESE CORPORATION (US) 1990-03-27 US claimed
EP-3303057-B1 METHOD OF BONDING HARDWARE TO GLASS 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-05-27 EP disclosed
US-20260139161-A1 Electrically Debondable UV Activated Adhesives 3M INNOVATIVE PROPERTIES CO (US) 2026-05-21 US disclosed
US-20260071098-A1 ULTRAVIOLET-BLOCKING ADHESIVE COMPOSITION, METHOD FOR PREPARING ADHESIVE RESIN BY USING SAME, AND ADHESIVE FILM MANUFACTURED USING SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2026-03-12 US disclosed
EP-4602109-B1 ELECTRICALLY DEBONDABLE UV ACTIVATED ADHESIVES 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-03-04 EP disclosed
EP-4696755-A1 ULTRAVIOLET-BLOCKING ADHESIVE COMPOSITION, METHOD FOR PREPARING ADHESIVE RESIN BY USING SAME, AND ADHESIVE FILM MANUFACTURED USING SAME Seoul National University R&DB Foundation (KR) 2026-02-18 EP disclosed
US-12545813-B2 Electrically debondable UV activated adhesives 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-10 US disclosed
US-20260008941-A1 ARTICLES COMPRISING CYCLIC OLEFIN, CATALYST, AND SECOND POLYMERIZABLE MATERIAL, METHODS AND COMPOSITIONS 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-01-08 US disclosed
US-20260008943-A1 ADHESIVE COMPOSITION COMPRISING POLAR (METH)ACRYLATE MONOMER AND EPOXY RESIN, ARTICLES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-01-08 US disclosed
US-20250376601-A1 PHOTOCATALYST COMPOSITION, PHOTOCURABLE COMPOSITION COMPRISING SAME AND METHOD FOR PREPARING PHOTOCURED RESIN BY USING SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2025-12-11 US disclosed
US-7771911-B2 Process for producing photoresist composition, filter, coater and photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 2010-08-10 US disclosed
US-7326512-B2 Polymer compound, resist composition and dissolution inhibitor agent containing the polymer compound TOKYO OHKA KOGYO CO., LTD. (JP) 2008-02-05 US disclosed
US-7179399-B2 Material for forming protective film TOKYO OHKA KOGYO CO., LTD. (JP) 2007-02-20 US disclosed
US-20060014098-A1 Process for producing photoresist composition, filter, coater and photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 2006-01-19 US disclosed
EP-1574901-A1 PROCESS FOR PRODUCING PHOTORESIST COMPOSITION, FILTER, COATER AND PHOTORESIST COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2005-09-14 EP disclosed
US-20050130056-A1 Polymer compound, resist composition and dissolution inhibitor agent containing the polymer compound UBS AG, STAMFORD BRANCH 2005-06-16 US disclosed
US-6693049-B2 FILLING WITH AN OXYALKYLATED MELAMINE, BENZOGUANAMINE, ACETOGUANAMINE, GLYCOL URYL, UREA, THIOUREA, GUANIDINE, ALKYLENEUREA OR SUCCINYLAMIDE AND HEATING AT 150-250 C, WHEREBY NO BUBBLE IS GENERATED WHEN THE FINE HOLE IS FILLED. TOKYO OHKA KOGYO CO., LTD. (JP) 2004-02-17 US disclosed
US-20030032280-A1 Method for filling fine hole TOKYO OHKA KOGYO CO., LTD. (JP) 2003-02-13 US disclosed
US-20020182360-A1 Material for forming protective film TOKYO OHKA KOGYO CO., LTD. (JP) 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071098-A1 ULTRAVIOLET-BLOCKING ADHESIVE COMPOSITION, METHOD FOR PREPARING ADHESIVE RESIN BY USING SAME, AND ADHESIVE FILM MANUFACTURED USING SAME CDH1, ITGAM, ICAM1 STAT3 4302/4885BACE1 2195/4885ABL1 3103/4885
US-20260008941-A1 ARTICLES COMPRISING CYCLIC OLEFIN, CATALYST, AND SECOND POLYMERIZABLE MATERIAL, METHODS AND COMPOSITIONS MAT2A, MAT1A, ALOX12 STAT3 4606/4885BACE1 1902/4885ABL1 2608/4885
US-20260139161-A1 Electrically Debondable UV Activated Adhesives CDH1, ITGB6, ITGA6 STAT3 3338/4885BACE1 2279/4885ABL1 2722/4885
US-12545813-B2 Electrically debondable UV activated adhesives CDH1, ITGB6, ITGA6 STAT3 3348/4885BACE1 2293/4885ABL1 2217/4885
US-20260008943-A1 ADHESIVE COMPOSITION COMPRISING POLAR (METH)ACRYLATE MONOMER AND EPOXY RESIN, ARTICLES AND METHODS CAD, METTL3, MAT1A STAT3 3537/4885BACE1 4805/4885ABL1 799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.